Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW0202 / 1||LA / IM|
Administered by: Pharmacy Purchased by: ??
Symptoms: Fatigue, Gait disturbance, Joint swelling, Nausea, Pain, Rash, Rash pruritic, Rash vesicular
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: Rasuvo, carvedilol, tylenol #4, pilocarpine, alprazolam, escitalopram, potassium, pantoprazole, olmesartan-hctz, tizanidine, folic acid, Simponi Aria
Current Illness: n/a
Preexisting Conditions: RA, fibromyalgia, hypertension
Diagnostic Lab Data: n/a
CDC 'Split Type':
Write-up: Patient received the first dose of the Pfizer COVID-19 vaccine on Wednesday, June 30. She reports that 2 days later, on Friday, July 2, she broke out in a rash from head to toe that lasted about a week. She reports the rash was itchy and started to blister the following day, on Saturday. She also reports she had body aches that made it difficult to walk, as well as fatigue, joint swelling, and nausea. She contacted her rheumatologist about the reaction and was instructed to take prednisone 10 mg for 2 days. She reports this helped, and the rash subsided. Her rheumatologist recommended against taking the second dose of the vaccine. Her primary care physician agreed.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166